Norgestimate: overview of a monophasic formulation.
Anderson
F D
FD
Product Development Center, Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk.
Gillmer
M D
MD
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D050260:Carbohydrate Metabolism; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects / Q000494:pharmacology*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects / Q000494:pharmacology; D004338:Drug Combinations; D004717:Endometrium / Q000187:drug effects; D004997:Ethinyl Estradiol / Q000009:adverse effects / Q000494:pharmacology; D019304:Ethinyl Estradiol-Norgestrel Combination / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D050356:Lipid Metabolism; D009644:Norgestrel / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D010060:Ovulation / Q000187:drug effects; D011372:Progestins / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D011817:Rabbits; D011944:Receptors, Androgen / Q000378:metabolism; D012738:Sex Hormone-Binding Globulin / Q000032:analysis; D013739:Testosterone / Q000097:blood
D003277:Contraceptives, Oral, Combined; D003280:Contraceptives, Oral, Synthetic; D004338:Drug Combinations; D011372:Progestins; D011944:Receptors, Androgen; D012738:Sex Hormone-Binding Globulin; C109079:norgestimate, ethinyl estradiol drug combination; D009644:Norgestrel; D013739:Testosterone; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination; C017576:norgestimate